PLOZALIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 23:23:01 GMT 2025` Edited by `admin` on `Mon Mar 31 23:23:01 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1\|KAPPA
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	4XG66BMN0D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

plozalizumab [INN]

Preferred Name

English

PLOZALIZUMAB

Official Name

English

HU-1D9

Code

English

MLN-1202

Code

English

HU1D9

Code

English

MLN1202

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CC CHEMOKINE RECEPTOR CCR2) (HUMAN-MUS MUSCULUS MONOCLONAL 1D9 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 1D9 .KAPPA.-CHAIN, DIMER

Common Name

English

Plozalizumab [WHO-DD]

Common Name

English

PLOZALIZUMAB [USAN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C1742

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

NCI_THESAURUS

C20401

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

NCI_THESAURUS

C129822

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

Code System Code Type Description

WIKIPEDIA

Plozalizumab

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

DRUG BANK

DB12520

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

FDA UNII

4XG66BMN0D

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

USAN

CD-117

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

CAS

1610761-46-0

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

SMS_ID

300000021898

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

ChEMBL

CHEMBL3707228

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

INN

10124

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

NCI_THESAURUS

C88308

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

ChEMBL

CHEMBL2109339

Created by admin on Mon Mar 31 23:23:01 GMT 2025 , Edited by admin on Mon Mar 31 23:23:01 GMT 2025

PRIMARY

From	To
1_22	1_98
1_144	1_200
1_261	1_321
1_367	1_425
2_22	2_98
2_144	2_200
2_261	2_321
2_367	2_425
3_23	3_93
3_139	3_199
4_23	4_93
4_139	4_199
1_220	3_219
2_220	4_219
1_226	2_226
1_229	2_229

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_297
N	2_297

Related Record Type Details


					P5H59ZL4XA

Plozalizumab Plevistinag

CONJUGATE -> PARENT

Amount:


					5XA76PCG9F

C-C CHEMOKINE RECEPTOR TYPE 2

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					4XG66BMN0D

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID REMOVAL	[1_447] [2_447]	C-TERMINUS	K		LYSINE	K3Z4F929H6

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL